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ABSTRACT  
Background: Evolutionary research on drug abuse has hitherto been restricted to proximate 
studies, considering aetiology, mechanism, and ontogeny. However, in order to explain the 
recent emergence of a new behavioural pattern (e.g. ‘the e-psychonaut style’) of novel 
psychoactive substances’ (NPS) intake, a complementary evolutionary model may be needed. 
Objective: A range of evolutionary interpretations on the ‘psychonaut style’ and the recent 
emergence of NPS was here considered 
Method: The PubMed database was searched in order to elicit evolutionary theory-based 
documents commenting on NPS/NPS users/e-psychonauts. 
Results: The traditional ‘shamanic style’ use of entheogens/plant-derived compounds may 
present with a range of similarities with the ‘e-psychonauts’ use of mostly of 
hallucinogen/psychedelic NPS. These users consider themselves as ‘new/technological’ 
shamans.  
Conclusion: Indeed, a range of evolutionary mechanisms, such as: optimal foraging; costly 
signalling; and reproduction at the expense of health; may all cooperate to explain the recent 
spread and diffusion of the NPS market, and this may represent a reason of concern. 
 
Keywords: evolutionary models; dual inheritance models; emotions; novel psychoactive 
substances; NPS; entheogens; psychonauts; shamanism; evolution; psychiatry; adeptness; 
costly signalling; handicap principle; fitness.   
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1. Introduction  
In order to fully understand and adequately explain any behaviour, including 
drug initiation/abuse, a range of issues, that may be schematically ranked in proximate 
(e.g. causation/mechanisms; and ontogeny/developmental trajectory) and 
ultimate/evolutionary (e.g. survival value/biological fitness and 
evolutionary/phylogenetic history), should be considered [1-2].     
Nowadays, there are many different classes of substances available for abuse, 
including several hundreds of novel psychoactive substances (NPS) [3-6]. Some of these 
drugs are entirely synthetic whilst others either occur naturally in plants, or are 
chemically modified from plant compounds [3-5]. It has been well documented the 
history of the co-evolution of humans with some plant toxins [7-9], mainly due to their 
antiparasitic/antibacterial properties [10-11]. Humans have learnt how to cultivate, 
modify and take advantage of these chemicals and, according to the ‘Dual Inheritance’ 
theory [12-13], have passed on this cultural knowledge to others [14-20]. These plant 
molecules have been ingested by humans over millennia for their advantageous 
evolutionary benefits as well as for their ritual/healing effects amongst shamanic 
cultures [19]. Hence, one would argue that the use of a range of these natural 
substances, from which the NPS are mainly derived, has a long evolutionary history [14-
16, 18-20].   
Evolutionary concepts open new perspectives on why and how these natural 
plant substances were identified, cultivated and exploited by our ancestors, but may 
also help explaining the recent spread of NPS market and the appearance of a new 
subculture of NPS enthusiasts/drug users, the so-called e-psychonauts [21]. Indeed, 
psychonauts define themselves as ‘shamans’, whilst showing psychological features and 
motivations different from those displayed by traditional drug users. At the same time, 
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the recent increasing levels of NPS ingestion worldwide [5-6] may represent an 
evolutionary challenge for our systems of adaptation, e.g. a proper ‘mismatch’ in terms 
of ability of our body to detoxify from these new compounds, arguably resulting in 
detrimental effects [17].  
In considering the above, we aimed here at providing an overview of a range of 
evolutionary interpretations of both drug/NPS initiation and misuse and the 
‘psychonaut style’ [21].  
 
2. Methods/Literature Search Strategy  
A literature search on PubMed was conducted using the following sets of 
keywords: (designer drugs OR Novel Psychoactive Substances OR NPS OR shamanism 
OR shaman OR psychonaut OR drug use OR drug abuse) AND (evolution OR 
evolutionary psychiatry OR Darwinian psychiatry OR Darwinian medicine OR 
evolutionary medicine). No language or time restrictions were placed on the electronic 
search, covering the period up to March 2016. No filters were applied to limit the 
retrieval process, although the primary focus was here on human studies. Articles of 
relevance were used as sources of further papers via references. Personal archives of 
reference, including textbooks, by leading experts in the field were further identified 
and analysed. The search was performed independently by LO and PStJS, with kappa 
levels of agreement being 0.8. data were compared and discrepancies were settled, if 
needed, with the supervision of FS. With the initial set of keywords, some 38,544 studies 
were identified. Of these, 15,454 were excluded because focusing on preclinical/animal 
research whilst 17,759 did not meet the inclusion criteria. Out of remaining 5,331 
studies, 5,230 were excluded because not consistent with the aims of the present study, 
leaving a total of 101 documents to be considered in this review.     
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3. Drug initiation and misuse; evolutionary and ethological perspectives  
A number of evolutionary concepts relating to the vulnerability to drug initiation and 
persistence of misuse were here selected, including: the ‘mismatch’ theory; tradeoffs; 
protective behaviour, defences and emotions; pharmacophagy and related infection control; 
reproduction at the expense of health; the costly signalling behaviour; the handicap 
hypotheses; the optimal foraging theory; the cultural reputation; and the influence of 
religion/spirituality on drug ingestion [9, 12-13, 17, 22-55].  
3.1. the Mismatch theory is based on the idea that humans possess traits/behavioural 
patterns that have been selected for, and preserved by, the natural selection process because 
of their adaptive function in a specific environment (e.g. the Environment of Evolutionary 
Adaptation; EEA), which was unlike the current one [30]. Hence, our ‘ancient’ adaptive traits 
may be largely ‘mistuned/mismatched’ to the current environment. These mismatch levels 
may be further enhanced by the constant/rapid/relentless engineering of previously unknown 
NPS [3-6], whose availability may strongly hinder the adaptation of humans’ biological 
systems. 
3.2. Tradeoffs. Selected traits and related adaptations often had to involve tradeoffs or 
compromises. For example, when males advertise for mates, they often produce some signals 
which are meant to affect the females’ choice [56]. Females often prefer those signals 
indicating that the candidate male partner may provide high fitness alleles and/or material 
resources to females/offsprings [35, 49, 57]. From this point of view, the risky/costly/tradeoff 
use of plants/drugs, including the most recent NPS, may be exploited by some individuals 
since this may confer some evolutionary advantage in a specific environment.  
3.3. Protective behaviour, defences and emotions. Both survival and reproductive 
success (Darwinian fitness) are unsurprisingly rewarded through positive emotions (e.g. 
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happiness, pleasure, excitement) [58]. Conversely, behaviours that are likely to overall 
decrease fitness levels produce aversive or negative emotions (e.g. pain, depression, anxiety, 
and fatigue). Many misusing substances usually hijack or override the brain’s natural reward 
and punishment centres [22-23, 27-28, 33, 36, 39, 52], with the largely pleasurable effects of 
these drugs often leading the user to feel that drug intake confers fitness advantages [48]. 
Furthermore, drug intake may represent a protective defence against an unpleasant/hostile 
environment. For example, stimulant ingestion may help in obtaining/maintaining adequate 
levels of performance, energy and working ability. 
3.4. Pharmacophagy and infection control. Many psychotropic substances present 
with bactericidal and/or antiparasitic effects, hence assisting in infection 
prevention/elimination [9]. In both human and non-human species [11, 41, 59-60], these 
antiparasitic effects may have originally been an unintentional by-product of diet/herbs’ 
intake, with eventual selection/related adaptation for a taste of these compounds [41, 61-62].  
3.5. Increasing reproductive fitness; reproduction at the expense of health: 
Although counterintuitive, a trait that significantly increases reproduction will tend to spread, 
even if it harms the health of individual. In the EEA environment, investments in competitive 
ability/risky behaviours were sexually selected by males in order to achieve greater 
reproductive payoffs [37, 43-44, 47]. These considerations may also explain early drug use 
‘to show off’, e.g. impress potential sexual partners.  
3.6. Costly signalling theory explains the evolutionary value of apparently wasteful 
behaviour (i.e. altruism) involving some levels of ‘sacrifice’ [24, 38]. High quality signallers 
are more successful in acquiring mates or allies, with signals being either ‘honest’, indicating 
superior biological value, or ‘false’ (e.g. implicating cheating), when they mislead about the 
real underlying biological value of the signaller. Shamans’ psychoactive plants’ ingestion was 
considered by the tribe components as a proper risky behaviour ‘per se’, hence perceived as 
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both altruistic and honest [63-64]. Similarly, the psychonautic behaviour, e.g. the decision to 
ingest a range of substances whilst sharing the on-drug subjective effects with the 
community, is considered a shaman-like/altruistic behaviour [65].  
3.7. Handicap principle [32]: Disadvantaged, drug using, males who can still 
demonstrate superiority, such as winning a fight, may in this way demonstrate their strength, 
fitness and bravery to potential mates. Therefore, even though a handicap/high-risk strategy, 
early drug use may signal bravery and thereby increase the chance of reproduction within a 
range of specific environments. Indeed, early drug taking may be associated with precocious 
sexual activity and teenage pregnancy [66-69]. 
3.8. Optimal foraging theory [26, 34, 45]: under conditions of scarcity/low prospect 
of future success, a strategy of caution will lead to death, whilst a short-term/high-risk 
strategy may lead to survival. From this perspective, for people who feel that they have ‘little 
to lose’, it may be an adaptive strategy to engage in greater risk taking behaviour/activities. 
Disinhibition due to substance use can lead to easier mating encounters, hence increasing the 
chances of reproducing [70-71].  
3.9. Cultural reputation [30]: Naming, branding and packaging are some of the ways 
in which the ‘cultural reputation’/meaning of different drugs is manipulated to influence 
consumers [72]. The ‘reputation’ of NPS is clearly amplified by their virtual dissemination 
through the internet and social networks [21, 73].  
 3.10. Religion, spirituality and ancient rituals’ ceremonies. Religion and spirituality 
appear to have co-evolved with a larger hominid brain capable of consciousness and a sense 
of agency [25, 29, 31, 74-75]. In order to demonstrate loyalty to the group, religious rituals 
are typically carried out in public, involve costly/elaborated ceremonies and customs, hence 
are associated with large placebo effects [53-54]. Although plant/drug intoxication rituals 
appear counterintuitive and paradoxical in evolutionary fitness terms [46, 51], sharing the 
      
8 
 
related spiritual experiences may confer advantages by increasing group cohesion [42, 76-
82].  
 
4. Shamanism and the entheogen/psychedelic use in shamanic practices   
Shamans [83] are often selected for having visions or signs from gods whilst going 
through trance states through a variety of procedures, which typically include 
hallucinogen/entheogen intake [64]. Religious/shamanic rituals are universally observed in all 
cultures, hence suggesting an evolutionary origin/survival value [84-88], with mild forms of 
schizophrenia possibly having enhanced shaman’s ability [89-91].  
Entheogens (etymologically, ‘that which causes God to be within an individual’) are 
typically psychedelics/hallucinogens [92] which generate transcendental feelings and/or 
hallucinatory experiences being traditionally interpreted as spirit visitations [93]. A variety of 
hallucinogenic mushrooms and plants, such as psilocybin mushrooms, Ayahuasca, peyote, 
cannabis, Salvia divinorum have been/are being used in rituals by shamans throughout the 
world [93-97]. Interestingly, club drugs (e.g. ecstasy and ketamine) have been associated in 
dance/party settings with a spiritual awakening of self-awareness; sense of liberation [98], 
and mystical experiences [99].  
 
5. Novel psychoactive substances  
NPS are usually synthetic molecules that may have effects and active constituents 
similar to plant drugs [3-5]. The short time-frame from NPS synthesis to 
ingestion/exploitation means natural evolution of tolerance or resistance to them cannot 
possibly have taken place (‘mismatch theory’). Many NPS are so new they cannot have been 
formally tested in animals yet, putting indeed drug users at risk [3-6].  
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In line with what suggested here in commenting about both the ‘cultural reputation’ 
and ‘dual inheritance’ theories, the use and sales of NPS for psychotropic purposes may well 
depend on cultural factors such as fashion, attractive naming, labelling, and the online ‘word 
of mouth’ knowledge [5, 73]. Overall, according to the ‘reproduction at the expense of 
health’ theory, and despite the NPS consumption being a risky strategy, for each macro-
family of NPS [5] a specific evolutionary/adaptive correlate could be identified:  
-Psychostimulant/amphetamine-like drugs (e.g. novel stimulants such as 4,4-DMAR, 
methiopropamine, modafinil; ethylphenydate; synthetic cathinones; synthetic cocaine 
substitutes; MDMA-like drugs; piperazines): main related adaptive advantages may be 
represented by: improved control on the natural environment by increased perceptual skills, 
time reaction to stimuli and resistance to stressors; decreased feelings of fatigue/sleep; and 
improvement of competitive strategies/academic performances.  
-Sedatives/anxiolytics/hypnotics (e.g. novel designer  benzodiazepines; synthetic 
opioids, GHB, etc): main adaptive advantages may be represented here by an increased 
control of anxiety/fear hence better coping strategies during life stressor events; an increased 
sexual disinhibition/availability for mating; and a better control of painful stimuli.  
-Entheogens/hallucinogens/dissociatives (e.g. synthetic cannabinoids/’Spice’ drugs; 
latest generation psychedelic phenethylamines such as NBOMe drugs; novel tryptamines 
derivatives.; phencyclidine/ketamine-like dissociative drugs; herbal highs such as Salvia 
divinorum, Mytragina speciose/’Kratom’ etc.): main adaptive advantages may be represented 
here by increased empathy levels, hence better establishment/strengthening of attachment 
bonds in a given environment; and improvement of own social status within specific 
environments. 
 
6. Psychonauts and e-psychonauts: self-appointed shamans?  
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The cultural reputation and attraction for NPS mainly derives from their use among 
the new drug users’ generation, the so-called psychonauts [100]. From an evolutionary point 
of view, psychonauts’ drug intake presents with similarities with the ancient shamanic ritual 
plant consumption. Indeed, psychonauts’ drug preference mainly refers to NPS with 
entheogen/hallucinogenic properties [21].  
The term ‘psychonaut’ was first introduced by Jünger [101] who described 
individuals who took psychoactive drugs with the stated intention of achieving greater 
knowledge of what he called the ‘inner universe’, whilst possibly addressing spiritual 
questions. Carroll [102] underlined the experimental use of drugs as appropriate tools to 
reach the state of ‘psychonaut’ (‘a sailor of the mind/soul’). For these reasons,  some consider 
psychonauts to be similar to traditional shamans [65]; ‘new/virtual shamans’ [21]; ‘chaos 
magickians’ [103]; ‘techno-shamans’ [104-106]. Conversely, the term ‘e-psychonaut’ refer to 
‘psychonauts living in the information age’. Typically, these ‘psychedelic researchers’ or 
‘alchemists’ [107-109] are quite knowledgeable about pharmaceutical and chemical 
properties of drugs, having experiment with a range of psychoactives and typically reporting 
their experiences online to peers/other ‘psychonauts’ [105-106].  
Similar to shamans, the e-psychonauts may be conceived as a sub-cultural group which 
presents with its own specific ‘initiation rites’, e.g. the practices required by the communities 
to the novel psychonaut applicant. These requirements include the need to formally enlist to 
the chosen forum, so that both the applicant contribution/posts/entries, but also the threads 
proactively s/he follows overtime, can be properly scrutinized. During the eventual ‘trial 
phase’, the applicant will need to post a given number of ‘trip reports’ relating to a range of 
plant-derived substances/entheogens (‘...you cannot be a psychonaut without tripping on 
drugs that helps in exploring the mind’)[105]. The applicant will possess excellent 
language/descriptive skills, so that his/her on-drug/trip reports can be made available in an 
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accurate and precise way [110]. Once recognized as an ‘approved psychonaut’, the applicant 
will be able to access a range of areas within the forum whose access was previously denied. 
In association with this, the successful applicant will be provided with a range of codes which 
will allow him/her the access to a range of sites providing a vast range of NPS purchase 
opportunities and located on the darknet/deep web [73].  
Similar to shamans, e-psychonauts’ main beliefs and goals have more often to do with 
the achievement of altered states of consciousness rather than with recreational purposes 
[105, 109]. Furthermore, the extensive level of web sharing activities facilitates the spread 
and selection of the ‘psychonaut cultural phenotype’ [105]. Cooperation, sharing and 
coordination with others are associated with evolutionary benefits [111]. Within the 
psychonauts’ communities, the intake of psychedelics is considered the trait d’union of e-
psychonauts, a ritual form of bonding which facilitates as well the psychedelic information 
flow [112]. Consistent with these observations, there is some evidence that psychedelic drug 
users report greater concern for others compared to both other drugs’ users and drug naïve 
subjects [99, 113-114]. In social interactions, approval and disapproval are most typically 
signalled by facial expressions [115-117]. Conversely, e-psychonauts rely on their written 
linguistic skills only for sharing the drug intake experiences [21].  
 
7. Discussion  
The evolutionary perspective here considered may shed further light on some of the 
underlying mechanisms of drug initiation and abuse; neo-shamanism; and NPS use. The 
observation that psychotropic drugs act on evolutionarily preserved motivational systems is 
consistent with the fact that, similar to humans, a range of mammals demonstrate compulsive 
self-administration of these same molecules/plants/herbs [39, 118]. Analyses of humans’ 
ancestral diets reveal wide use of psychoactive plant chemicals by early hominids, possibly 
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conferring alertness, overcoming exhaustion, and appetite suppression, whilst presenting with 
bactericidal and anti-parasitic properties [55].   
Nowadays, the fervent NPS market opens up new perspectives on self-
experimentation and self-medication. However, there is a mismatch between the availability 
and strength of these new compounds and the mechanisms that humans have developed to 
cope with them, only resulting in extremely detrimental disadvantages in terms of survival 
and health. Conversely, since drug/NPS ingestion is a risky behaviour, hence an ‘honest 
signal’ indicating bravery or vigour, this may somehow increase the drug user’s sexual 
attraction. When prospects of success are very low, high-risk strategies confer at least the 
possibility of success, and may be adaptive [119]. Furthermore, in some cultural sub-groups, 
as here discussed, hallucinogenic/dissociative NPS would arguably confer adaptive 
advantages in terms of improved social status.  
Further studies should be carried out to better understand the cultural/evolutionary 
background of the current increasing levels of NPS misuse.  
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